Neovascular Glaucoma in Diabetes: What You Need to Know
How Neovascular Glaucoma Develops in Diabetic Eyes
Neovascular glaucoma does not appear on its own. It is almost always a consequence of advanced diabetic eye disease, and understanding the steps that lead to it can help you appreciate why consistent monitoring and treatment matter so much.
Neovascular glaucoma is closely connected to proliferative diabetic retinopathy (PDR), the most advanced stage of diabetic eye disease. In PDR, widespread closure of the tiny blood vessels in the retina (the light-sensing layer at the back of the eye) leaves large areas without enough oxygen. The oxygen-starved retina then releases a chemical signal called vascular endothelial growth factor, or VEGF, which stimulates the growth of new, abnormal blood vessels. These vessels can spread from the retina forward into other structures of the eye, including the iris (the colored part of the eye) and the drainage channel where fluid exits the eye. This forward movement is what triggers neovascular glaucoma.
The eye continuously produces a clear fluid called aqueous humor that nourishes the front of the eye and maintains its shape. This fluid exits through a structure called the trabecular meshwork, located in the drainage angle where the iris meets the cornea (the clear front surface of the eye). When abnormal blood vessels invade this area, they obstruct fluid outflow. Over time, a sheet of fibrous tissue forms alongside the vessels and contracts, closing the drainage angle further. When the angle closes, pressure inside the eye can rise rapidly to dangerously high levels, damaging the optic nerve, which is the bundle of nerve fibers that carries visual information from the eye to the brain.
Neovascular glaucoma moves through recognizable stages. The earliest stage, called rubeosis iridis, involves the growth of new blood vessels on the surface of the iris. At this point, the drainage angle may still be partially open and eye pressure may be close to normal. As the vessels spread into the drainage angle, obstruction increases and pressure begins to rise. In the final stage, fibrous tissue permanently closes the angle, creating a condition that is very difficult to reverse. Catching the disease during the rubeosis iridis stage offers the best chance of preserving vision before lasting damage occurs.
When proliferative diabetic retinopathy is not treated promptly, elevated VEGF levels continue to drive abnormal vessel growth not only on the retina but also forward onto the iris and into the drainage angle. Without intervention to lower VEGF and treat the oxygen-deprived retina, progression from PDR to neovascular glaucoma becomes increasingly likely over time. This is why prompt, effective treatment of PDR is so critical. Addressing PDR early stops the chain of events that leads to this severe complication.
Symptoms and Warning Signs
Neovascular glaucoma presents differently from most other forms of glaucoma. Rather than developing without symptoms, it often announces itself with signs that require immediate attention. Knowing what to watch for can make a significant difference in outcomes.
A rapid rise in eye pressure causes the wall of the eye to stretch and the internal nerves to become irritated, resulting in sudden, severe pain. The eye may also become visibly red due to congestion of surface blood vessels caused by the high internal pressure. These symptoms stand in sharp contrast to common open-angle glaucoma, which is typically painless. If you have diabetes and develop sudden eye pain with redness, seek immediate evaluation from your eye doctor or go to an emergency facility with eye care capabilities right away.
The elevated pressure in neovascular glaucoma damages the optic nerve, and vision can deteriorate rapidly over days to weeks if pressure is not controlled. Vision loss may begin as blurriness or haziness and progress to severe impairment. Bleeding from abnormal vessels inside the eye can compound the problem by blocking light from reaching the retina. The combination of high pressure, optic nerve damage, and potential bleeding makes neovascular glaucoma one of the most vision-threatening complications of diabetes, making early recognition and treatment essential.
As pressure rises, the cornea can become swollen, causing light to scatter as it enters the eye. This produces rainbow-colored halos around light sources, particularly at night. Vision may also appear foggy or hazy, as though looking through a frosted window. These symptoms may come and go at first if the pressure fluctuates. Persistent halos or foggy vision in a person with known diabetic retinopathy should prompt a visit to your eye doctor for a pressure check without delay.
Before any symptoms appear, a thorough eye examination can reveal early warning signs. New blood vessels on the surface of the iris, the hallmark finding of rubeosis iridis, can be detected during a slit-lamp exam (a microscopic evaluation using a bright light and a magnifying lens). Your eye doctor also examines the drainage angle using a mirrored contact lens in a procedure called gonioscopy, which reveals whether abnormal vessels or fibrous tissue have begun to invade the angle. An unexplained rise in eye pressure at a routine visit can also signal early neovascular changes. Detecting these signs before symptoms develop allows treatment to begin when it is most effective.
How Neovascular Glaucoma Is Treated
Treating neovascular glaucoma requires addressing both the elevated eye pressure and the underlying vascular disease driving it. No single approach is sufficient on its own, and your care will typically involve a coordinated combination of treatments.
Anti-VEGF medications are typically the first line of treatment. These drugs are injected into the eye to block the growth factor that is fueling abnormal vessel formation. Anti-VEGF injections can cause new vessels on the iris and in the drainage angle to regress rapidly, often within days, reducing the physical obstruction of the drainage pathway and helping to lower pressure. This rapid effect creates a crucial window for additional treatments to be applied safely and effectively. Anti-VEGF therapy also helps reduce bleeding and inflammation before further procedures are performed.
Panretinal photocoagulation, or PRP, addresses the root cause of neovascular glaucoma by treating the oxygen-deprived retina. During PRP, a laser applies hundreds of small, precise burns to the peripheral retina, reducing the retina's oxygen demand and lowering VEGF production. With less VEGF circulating in the eye, the stimulus for abnormal vessel growth diminishes and existing vessels may shrink or stabilize over time. While anti-VEGF injections provide rapid but temporary VEGF suppression, PRP provides a more lasting reduction. In most cases, the two treatments are used together for both immediate relief and long-term control.
Prescription eye drops that reduce intraocular pressure are used alongside treatments targeting the abnormal vessels. Some drops reduce the amount of fluid the eye produces, while others increase the rate at which fluid drains. In neovascular glaucoma, these drops are an important part of management, but they are rarely sufficient on their own when the drainage angle is significantly compromised. Your eye doctor will select the most appropriate combination and monitor your pressure closely. In some cases, oral medications that reduce fluid production may also be prescribed temporarily when pressure is very high.
When anti-VEGF injections, laser treatment, and drops cannot adequately control pressure, surgery may be necessary. Glaucoma drainage implant surgery places a small device in the eye to create an alternative pathway for fluid to exit, bypassing the blocked drainage angle. In very advanced cases where the eye has lost useful vision and is causing significant pain, a procedure called cyclophotocoagulation applies laser energy to the part of the eye that produces fluid, reducing production and relieving pressure. Your eye doctor will recommend the most appropriate surgical option based on the severity of your condition and the amount of remaining vision.
How Neovascular Glaucoma Differs From Common Glaucoma
Understanding how neovascular glaucoma compares to the most common form of glaucoma helps clarify why it requires such a different and more urgent treatment approach.
The most prevalent form of glaucoma, primary open-angle glaucoma, develops when the eye's drainage system gradually becomes less efficient over many years, for reasons that are not always fully understood. Neovascular glaucoma has a specific, identifiable cause: the growth of abnormal blood vessels that physically block the drainage pathway as a direct result of advanced diabetic retinopathy. Because it has a known underlying cause, treatment must also address that cause, not just the pressure, to be effective long term.
Open-angle glaucoma typically progresses over years without noticeable pain or sudden symptoms, often going undetected until peripheral (side) vision is already reduced. Neovascular glaucoma can develop over weeks to months and cause rapid, severe vision loss alongside pain and redness. Eye pressure in neovascular glaucoma can reach much higher levels than in typical open-angle glaucoma, causing faster and more severe optic nerve damage. This urgency demands prompt and aggressive intervention.
Open-angle glaucoma is generally managed with pressure-lowering drops, selective laser treatments, or drainage surgery. Neovascular glaucoma requires all of these plus anti-VEGF injections and panretinal photocoagulation laser to address the underlying retinal disease. This multi-pronged approach, targeting both the pressure and the root cause, is what distinguishes neovascular glaucoma treatment from standard glaucoma management.
When detected at the rubeosis iridis stage, before the drainage angle is permanently closed, the outlook is more favorable. Anti-VEGF injections can cause new vessels to regress, and PRP can reduce the likelihood of their return. Once the drainage angle is permanently scarred shut, pressure becomes much harder to control and optic nerve damage may already be advanced. Even with surgical drainage devices, late-stage neovascular glaucoma can be challenging to manage over the long term. Early detection truly makes a meaningful difference in outcomes.
Preventing Neovascular Glaucoma
Prevention is always the most effective strategy, and in the case of neovascular glaucoma, meaningful prevention is possible through consistent care and good diabetes management.
The most powerful prevention strategy is treating diabetic retinopathy before it reaches the proliferative stage. Regular dilated eye exams detect retinopathy at its earliest stages, when timely treatment can slow or halt progression. If retinopathy does advance to the severe nonproliferative or proliferative stage, prompt treatment with PRP and anti-VEGF injections significantly reduces VEGF levels and stops the chain of events that leads to neovascular glaucoma. Patients diagnosed with high-risk proliferative diabetic retinopathy should receive treatment without delay.
Keeping blood sugar within your target range slows damage to the tiny blood vessels in the retina across all stages of diabetic eye disease. Good blood sugar management reduces the ongoing vascular damage that drives VEGF production. Controlling blood pressure adds an additional layer of protection by reducing mechanical stress on already compromised retinal vessels. Together, blood sugar and blood pressure management form the foundation of diabetic eye disease prevention, including prevention of neovascular glaucoma.
Annual dilated eye exams are the minimum standard for any person with diabetes, and more frequent visits are recommended once retinopathy has been identified. At each visit, your eye doctor examines not only the retina but also the iris and drainage angle, watching for early neovascular changes. If rubeosis iridis or early angle involvement is detected, treatment can begin immediately, before the condition progresses to elevated pressure and optic nerve damage. Keeping your scheduled appointments is one of the most effective steps you can take to prevent this serious complication.
Frequently Asked Questions
Below are answers to some of the questions we hear most often from patients and families concerned about neovascular glaucoma and its relationship to diabetes.
New vessels on the iris, known as rubeosis iridis, are an early warning sign that neovascular glaucoma may be developing. This finding is significant and should not be ignored, but detecting it early is actually advantageous. At this stage, the drainage angle may still be open and pressure may be near normal, which means treatment with anti-VEGF injections and laser can often stop progression before pressure rises or vision is affected. Act promptly, attend any follow-up appointments your eye doctor schedules, and make sure your diabetic retinopathy is being managed aggressively.
Yes, and this is one of the most important reasons to attend regular eye exams even when you feel fine. In the early rubeosis iridis stage, there may be no pain, no redness, and no noticeable change in vision. Your eye doctor can detect abnormal vessels and early drainage angle changes during examination before any symptoms appear. Waiting for symptoms before seeking care puts you at risk of being diagnosed at a much more advanced stage, when treatment is harder and vision loss may already be significant.
Anti-VEGF injections are highly effective at rapidly reducing abnormal vessels and lowering pressure, but they do not address the underlying retinal disease that is producing VEGF in the first place. Their effect on VEGF suppression is temporary. Panretinal photocoagulation laser treatment is needed to provide a more lasting reduction in VEGF production by treating the oxygen-deprived retina. Long-term control typically requires both approaches, along with ongoing monitoring and, in some cases, pressure-lowering medications or surgery. Your treatment plan will be tailored to your specific situation.
Not necessarily. Even after a diagnosis of neovascular glaucoma, treatment can stabilize pressure, reduce abnormal vessels, and help preserve the vision that remains. The amount of vision that can be protected depends on how much optic nerve damage has already occurred and how quickly treatment begins. Eyes treated at an early stage, before the drainage angle is permanently scarred, tend to respond better. If significant optic nerve damage has already occurred, some vision loss may be irreversible, but preventing further loss is still a meaningful and achievable goal. Prompt evaluation and treatment give you the best chance.
It can, particularly if both eyes have advanced diabetic retinopathy with significant areas of oxygen-deprived retina. However, both eyes do not necessarily develop the condition at the same time. If neovascular glaucoma is identified in one eye, your eye doctor will carefully monitor the other eye for similar changes at each visit. Treating any existing retinopathy in the other eye aggressively and maintaining strong blood sugar control can reduce the risk of it developing there as well. A diagnosis in one eye should prompt more vigilant management of both.
The frequency of exams is determined by your eye doctor based on the severity and stability of your retinopathy, your treatment history, and your overall diabetes control. For many patients with active or high-risk proliferative diabetic retinopathy, follow-up visits more frequent than once a year are appropriate. Your eye doctor may recommend exams every few months, or even more frequently during active treatment. Between appointments, be alert to any new symptoms such as eye pain, redness, halos around lights, or a sudden change in vision, and seek evaluation promptly if any of these occur.
Schedule an Evaluation at Rhode Island Eye Institute
If you have diabetes and have concerns about your eye health, we encourage you to schedule a comprehensive evaluation with our team at Rhode Island Eye Institute. Our specialists have extensive experience managing diabetic eye disease at every stage, including the early detection and treatment of neovascular glaucoma. We are here to provide expert, compassionate care and to help you protect your vision for the long term.